AVCURI
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Feb 2026)
What this means for you
This application is over — abandoned 16 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97196466
- Mark type
- Stylized text
- Filed
- 30 Dec 2021
- Published for opposition
- 22 Nov 2022
- Abandoned
- 16 Feb 2026
- Attorney of record
- Michael E. Dukes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations
Owner
- Actinium Pharmaceuticals, Inc., New York, NY, US
- Actinium Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 16 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 5 GRANTED
- 07 Jul 2025 — SOU EXTENSION 5 FILED
- 12 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2024 — SOU EXTENSION 4 GRANTED
- 19 Dec 2024 — SOU EXTENSION 4 FILED
- 19 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2024 — SOU EXTENSION 3 GRANTED
- 29 Apr 2024 — SOU EXTENSION 3 FILED
- 29 Apr 2024 — SOU TEAS EXTENSION RECEIVED